Literature DB >> 22585122

In vivo experimental stroke and in vitro organ culture induce similar changes in vasoconstrictor receptors and intracellular calcium handling in rat cerebral arteries.

Gro Klitgaard Povlsen1, Roya Waldsee, Hilda Ahnstedt, Kim Anker Kristiansen, Flemming Fryd Johansen, Lars Edvinsson.   

Abstract

Cerebral arteries subjected to different types of experimental stroke upregulate their expression of certain G-protein-coupled vasoconstrictor receptors, a phenomenon that worsens the ischemic brain damage. Upregulation of contractile endothelin B (ET(B)) and 5-hydroxytryptamine 1B (5-HT(1B)) receptors has been demonstrated after subarachnoid hemorrhage and global ischemic stroke, but the situation is less clear after focal ischemic stroke. Changes in smooth muscle calcium handling have been implicated in different vascular diseases but have not hitherto been investigated in cerebral arteries after stroke. Here, we evaluate changes of ET(B) and 5-HT(1B) receptors, intracellular calcium levels, and calcium channel expression in rat middle cerebral artery (MCA) after focal cerebral ischemia and in vitro organ culture, a proposed model of vasoconstrictor receptor changes after stroke. Rats were subjected to 2 h MCA occlusion followed by reperfusion for 1 or 24 h. Alternatively, MCAs from naïve rats were cultured for 1 or 24 h. ET(B) and 5-HT(1B) receptor-mediated contractions were evaluated by wire myography. Receptor and channel expressions were measured by real-time PCR and immunohistochemistry. Intracellular calcium was measured by FURA-2. Expression and contractile functions of ET(B) and 5-HT(1B) receptors were strongly upregulated and slightly downregulated, respectively, 24 h after experimental stroke or organ culture. ET(B) receptor-mediated contraction was mediated by calcium from intracellular and extracellular sources, whereas 5-HT(1B) receptor-mediated contraction was solely dependent on extracellular calcium. Organ culture and stroke increased basal intracellular calcium levels in MCA smooth muscle cells and decreased the expression of inositol triphosphate receptor and transient receptor potential canonical calcium channels, but not voltage-operated calcium channels.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22585122     DOI: 10.1007/s00221-012-3108-6

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  44 in total

1.  Selective up-regulation of 5-HT(1B/1D) receptors during organ culture of cerebral arteries.

Authors:  N L Hoel; J Hansen-Schwartz; L Edvinsson
Journal:  Neuroreport       Date:  2001-06-13       Impact factor: 1.837

Review 2.  Metabotropic Ca2+ channel-induced calcium release in vascular smooth muscle.

Authors:  Juan Ureña; Alberto del Valle-Rodríguez; José López-Barneo
Journal:  Cell Calcium       Date:  2007-06-07       Impact factor: 6.817

Review 3.  Endothelin receptors and calcium signaling.

Authors:  D M Pollock; T L Keith; R F Highsmith
Journal:  FASEB J       Date:  1995-09       Impact factor: 5.191

4.  Subarachnoid hemorrhage induces enhanced expression of thromboxane A2 receptors in rat cerebral arteries.

Authors:  Saema Ansar; Carl Larsen; Aida Maddahi; Lars Edvinsson
Journal:  Brain Res       Date:  2009-12-22       Impact factor: 3.252

Review 5.  Excitation-transcription coupling in arterial smooth muscle.

Authors:  Brian R Wamhoff; Douglas K Bowles; Gary K Owens
Journal:  Circ Res       Date:  2006-04-14       Impact factor: 17.367

6.  L-type voltage-gated Ca2+ channels modulate expression of smooth muscle differentiation marker genes via a rho kinase/myocardin/SRF-dependent mechanism.

Authors:  B R Wamhoff; D K Bowles; O G McDonald; S Sinha; A P Somlyo; A V Somlyo; G K Owens
Journal:  Circ Res       Date:  2004-07-15       Impact factor: 17.367

7.  Cerebral ischemia enhances vascular angiotensin AT1 receptor-mediated contraction in rats.

Authors:  Emelie Stenman; Lars Edvinsson
Journal:  Stroke       Date:  2004-03-04       Impact factor: 7.914

Review 8.  The non-excitable smooth muscle: calcium signaling and phenotypic switching during vascular disease.

Authors:  Suzanne J House; Marie Potier; Jonathan Bisaillon; Harold A Singer; Mohamed Trebak
Journal:  Pflugers Arch       Date:  2008-03-26       Impact factor: 3.657

9.  Intracellular pathways involved in upregulation of vascular endothelin type B receptors in cerebral arteries of the rat.

Authors:  Marie Henriksson; Emelie Stenman; Lars Edvinsson
Journal:  Stroke       Date:  2003-05-15       Impact factor: 7.914

10.  Ca2+ handling is altered when arterial myocytes progress from a contractile to a proliferative phenotype in culture.

Authors:  Roberto Berra-Romani; Amparo Mazzocco-Spezzia; Maria V Pulina; Vera A Golovina
Journal:  Am J Physiol Cell Physiol       Date:  2008-07-02       Impact factor: 4.249

View more
  12 in total

1.  MEK1/2 inhibitor U0126 but not endothelin receptor antagonist clazosentan reduces upregulation of cerebrovascular contractile receptors and delayed cerebral ischemia, and improves outcome after subarachnoid hemorrhage in rats.

Authors:  Gro K Povlsen; Lars Edvinsson
Journal:  J Cereb Blood Flow Metab       Date:  2014-11-19       Impact factor: 6.200

2.  Controversies and evolving new mechanisms in subarachnoid hemorrhage.

Authors:  Sheng Chen; Hua Feng; Prativa Sherchan; Damon Klebe; Gang Zhao; Xiaochuan Sun; Jianmin Zhang; Jiping Tang; John H Zhang
Journal:  Prog Neurobiol       Date:  2013-09-25       Impact factor: 11.685

3.  U0126 attenuates cerebral vasoconstriction and improves long-term neurologic outcome after stroke in female rats.

Authors:  Hilda Ahnstedt; Maryam Mostajeran; Frank W Blixt; Karin Warfvinge; Saema Ansar; Diana N Krause; Lars Edvinsson
Journal:  J Cereb Blood Flow Metab       Date:  2014-12-10       Impact factor: 6.200

4.  Male-female differences in upregulation of vasoconstrictor responses in human cerebral arteries.

Authors:  Hilda Ahnstedt; Lei Cao; Diana N Krause; Karin Warfvinge; Hans Säveland; Ola G Nilsson; Lars Edvinsson
Journal:  PLoS One       Date:  2013-04-29       Impact factor: 3.240

5.  Regulatory mechanism of endothelin receptor B in the cerebral arteries after focal cerebral ischemia.

Authors:  Anne-Sofie Grell; Rushani Thigarajah; Lars Edvinsson; Ajoy Kumar Samraj
Journal:  PLoS One       Date:  2014-12-05       Impact factor: 3.240

6.  Multimodal imaging reveals temporal and spatial microglia and matrix metalloproteinase activity after experimental stroke.

Authors:  Bastian Zinnhardt; Thomas Viel; Lydia Wachsmuth; Alexis Vrachimis; Stefan Wagner; Hans-Jörg Breyholz; Andreas Faust; Sven Hermann; Klaus Kopka; Cornelius Faber; Frédéric Dollé; Sabina Pappata; Anna M Planas; Bertrand Tavitian; Michael Schäfers; Lydia M Sorokin; Michael T Kuhlmann; Andreas H Jacobs
Journal:  J Cereb Blood Flow Metab       Date:  2015-07-01       Impact factor: 6.200

7.  MAPK signaling pathway regulates cerebrovascular receptor expression in human cerebral arteries.

Authors:  Saema Ansar; Sajedeh Eftekhari; Roya Waldsee; Elisabeth Nilsson; Ola Nilsson; Hans Säveland; Lars Edvinsson
Journal:  BMC Neurosci       Date:  2013-01-23       Impact factor: 3.288

8.  CaMKII and MEK1/2 inhibition time-dependently modify inflammatory signaling in rat cerebral arteries during organ culture.

Authors:  Roya Waldsee; Sajedeh Eftekhari; Hilda Ahnstedt; Leif E Johnson; Lars Edvinsson
Journal:  J Neuroinflammation       Date:  2014-05-16       Impact factor: 8.322

9.  Upregulation of 5-hydroxytryptamine receptor signaling in coronary arteries after organ culture.

Authors:  Chun-Yu Deng; Hui Yang; Su-Juan Kuang; Fang Rao; Yu-Mei Xue; Zhi-Ling Zhou; Xiao-Ying Liu; Zhi-Xin Shan; Xiao-Hong Li; Qiu-Xiong Lin; Shu-Lin Wu; Xi-Yong Yu
Journal:  PLoS One       Date:  2014-09-09       Impact factor: 3.240

10.  CaMKII inhibition with KN93 attenuates endothelin and serotonin receptor-mediated vasoconstriction and prevents subarachnoid hemorrhage-induced deficits in sensorimotor function.

Authors:  Lars Edvinsson; Gro Klitgaard Povlsen; Hilda Ahnstedt; Roya Waldsee
Journal:  J Neuroinflammation       Date:  2014-12-10       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.